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Death-associated protein kinase 1 phosphorylates
NDRG2 and induces neuronal cell death
Mi-Hyeon You1, Byeong Mo Kim1,2, Chun-Hau Chen3, Michael J Begley4, Lewis C Cantley4,5 and Tae Ho Lee*,1
Death-associated protein kinase 1 (DAPK1) has been shown to have important roles in neuronal cell death in several model
systems and has been implicated in multiple diseases, including Alzheimer’s disease (AD). However, little is known about the
molecular mechanisms by which DAPK1 signals neuronal cell death. In this study, N-myc downstream-regulated gene 2 (NDRG2)
was identified as a novel substrate of DAPK1 using phospho-peptide library screening. DAPK1 interacted with NDRG2 and directly
phosphorylated the Ser350 residue in vitro and in vivo. Moreover, DAPK1 overexpression increased neuronal cell death through
NDRG2 phosphorylation after ceramide treatment. In contrast, inhibition of DAPK1 by overexpression of a DAPK1 kinase-deficient
mutant and small hairpin RNA, or by treatment with a DAPK1 inhibitor significantly decreased neuronal cell death, and abolished
NDRG2 phosphorylation in cell culture and in primary neurons. Furthermore, NDRG2-mediated cell death by DAPK1 was required
for a caspase-dependent poly-ADP-ribose polymerase cleavage. In addition, DAPK1 ablation suppressed ceramide-induced cell
death in mouse brain and neuronal cell death in Tg2576 APPswe-overexpressing mice. Finally, levels of phosphorylated NDRG2
Ser350 and DAPK1 were significantly increased in human AD brain samples. Thus, phosphorylation of NDRG2 on Ser350 by
DAPK1 is a novel mechanism activating NDRG2 function and involved in neuronal cell death regulation in vivo.
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Death-associated protein kinase 1 (DAPK1) is a death
domain-containing calcium/calmodulin-regulated serine/
threonine kinase that was first identified by functional cloning
based on its involvement in interferon-γ-induced apoptosis.1,2
DAPK1 has been shown to promote apoptosis induced by
various stimuli, including ceramide, and seems to have a
particularly important role in the regulation of neuronal cell
death.1–11 DAPK1 overexpression and activation increase
neuronal cell death, and neurons without DAPK1 are less
sensitive to apoptotic stimuli both in vitro and in vivo.8,12–15
Moreover, DAPK1 modulates brain damage through the
N-methyl-D aspartate receptors, and inhibition of DAPK1
activity has neuroprotective effects in a mouse model of
ischemia.16–19 Furthermore, DAPK1 is activated by its depho-
sphorylation and promotes neuronal cell death in response to
unliganded UNC5H2 or Neogenin.8,13,20 Although DAPK1
could be a key factor that induces neuronal cell death at
multiple levels through regulating its substrates such as NR2B
and p53,8,10,16 the molecular mechanisms of DAPK1 involved
in neuronal apoptosis are not fully understood.
Recent studies have also indicated that DAPK1 may have a
critical role in neurodegenerative diseases, includingAlzheimer’s
disease (AD). Mice deficient in DAPK1 kinase activity are more
efficient learners and have better spatial memory compared with
wild-type (WT) mice.21 Moreover, despite previous conflicting
results, a recent large-scale genetic assay has identified DAPK1
as one of the genetic factors that may affect susceptibility to late-
onset AD.22–24 Recently, our lab showed that DAPK1 expression
is significantly upregulated in the hippocampi of AD patients
compared with age-matched normal subjects.25 Furthermore,
DAPK1promotes tau protein accumulation and phosphorylation,
and amyloidogenic APP processing.25–28 Finally, DAPK1 kinase
activity is responsible for Pin1 phosphorylation, which inhibits
Pin1 activity.29 As Pin1 protects against AD by regulating
phosphorylated tau and APP, DAPK1 deregulation may
contribute to AD by inactivating Pin1 activity.30
In the article, N-myc downstream-regulated gene 2 (NDRG2)
was identified as a novel DAPK1 substrate through a peptide
library approach. DAPK1 was found to bind to and phosphor-
ylate NDRG2. Moreover, NDRG2 might mediate and activate a
DAPK1-dependent neuronal cell death. The significance of
these findings was further substantiated that NDRG2 phos-
phorylation and DAPK1 levels were highly increased in human
AD brains. Taken together, these results show, for the first time,
that DAPK1 is a critical regulator of NDRG2both in neuronal cell
death and during the progression of AD.
Results
Identification of NDRG2 as a novel DAPK1 substrate.
Although several DAPK1 substrates involved in apoptotic
pathways have been identified, little is known about the direct
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substrates that are required for DAPK1 neuronal cell death.
To address this question, we conducted unbiased proteomic
and bioinformatics screens to identify possible DAPK1
substrates. A positional scanning peptide library assay was
performed to identify the optimal phosphorylation motif for
DAPK1, as reported.31,32 DAPK1 showed a strong prefer-
ence for substrates with Arginine residues at the -2 and -3
positions relative to the phosphorylation site (Supplementary
Figure 1). Spot intensities from the peptide library screen
were then quantified and converted into a matrix that could be
used in the bioinformatic search engine Scansite to identify
potential DAPK1 substrates. Supplementary Table 1 showed
top-scoring putative DAPK1 substrates through the statistical
criteria analysis in the SwissProt database. NDRG2 was
found to be the most intriguing for the following reasons:
(1) NDRG2 was scored in the top 0.1% in this screening.
(2) NDRG2 overexpression has been shown to increase
apoptosis;33–35 (3) NDRG2 expression is increased after
focal cerebral ischemia;36 (4) NDRG2 expression levels are
upregulated in human AD patient brains;37 (5) NDRG2
phosphorylation is increased in a neurodegenerative
diseases;38 and (6) NDRG2 single-nucleotide polymorphisms
occur in late-onset AD patients.39 These results suggest that
NDRG2 may have an important role in the regulation of
neuronal cell death and AD.
DAPK1 interacts with NDRG2 in vitro and in vivo. To
confirm whether NDRG2 is a putative DAPK1 substrate, we
first examined whether NDRG2 interacts with DAPK1. FLAG-
DAPK1 was co-immunoprecipitated by anti-Myc-NDRG2 in
293T or SH-SY5Y cells (Figure 1a and Supplementary
Figure 2a). Reverse co-immunoprecipitation also confirmed
that DAPK1 bound to NDRG2 (Figure 1b and Supplementary
Figure 2b). Moreover, endogenous DAPK1 and NDRG2 were
formed a complex in mouse whole-brain lysates (Figure 1c).
We further examined the DAPK1 and NDRG2 interaction
in vitro using GST pull-down experiments.29 GST-NDRG2,
but not control GST, bound to DAPK1 (Figure 1d). Moreover,
both constitutively active mutant DAPK1ΔCaM and kinase-
deficient mutant DAPK1K42A interacted with NDRG2
(Figure 1e), confirming that the kinase activity of DAPK1 is
not required for NDRG2 binding. When HeLa or SH-SY5Y
cells were co-transfected with GFP-NDRG2 and Myc-DAPK1
or its mutants and their subcellular localization was examined
directly, NDRG2 colocalized in the cytoplasm with DAPK1
(Figure 1f and Supplementary Figure 2c). Thus, NDRG2
interacts with DAPK1 in vitro and in vivo, and both are
colocalized in the cytoplasm.
To map the domains in NDRG2 and DAPK1 important for
their interaction, a series of DAPK1 mutants was generated
and used in vitro binding assay (Figure 2a). The DAPK1
fragments from 637 to 1423 efficiently bound to NDRG2,
suggesting that the cytoskeleton-binding region (637–847,
Cyto) is likely bound to NDRG2 (Figure 2b). Moreover, purified
His-DAPK1-Cyto directly bound to GST-NDRG2 (Figure 2c)
and GST-NDRG2 specifically bound to FLAG-DAPK1-Cyto
(Figure 2d). Furthermore, all mutants with altered
cytoskeleton-binding regions failed to interact with NDRG2
(Figure 2e). In addition, theGST-NDRG2 fragments (201–371)
efficiently bound to DAPK1 (Figure 2f). These results indicate
that the C-terminal domain of NDRG2 specifically binds to
DAPK1 via its cytoskeleton-binding domain.
DAPK1 phosphorylates NDRG2 on Ser350 in vitro and
in vivo. Given the specific interaction between DAPK1 and
NDRG2, we next examined whether DAPK1 phosphorylates
NDRG2. Recombinant DAPK1 was incubated with
GST-NDRG2 and GST-myosin light chain (MLC) as a positive
control.4 Both NDRG2 and MLC were phosphorylated by
DAPK1 in a time-dependent manner (Figures 3a and b).
DAPK1 efficiently phosphorylated NDRG2, whereas the Km
value of MLC was slightly lower than NDRG2 in the steady-
state kinetic parameters (Figure 3c). Importantly, DAPK1
phosphorylated only to the GST-NDRG2 fragment (201–371),
but not the GST-NDRG2 fragment (1–200) (Figure 3d),
suggesting that the putative phosphorylated site is located
in the C-terminal domain of NDRG2. To determine which
NDRG2 sites are phosphorylated by DAPK1, an Ala substitu-
tion was introduced into each of the six putative NDRG2
phosphorylation sites. Although DAPK1 efficiently phosphory-
lated NDRG2, Ser326A, Thr330A, Ser332A, Ser346A and
Thr348A, it failed to phosphorylate Ser350A (Figure 3e). To
detect phosphorylation of NDRG2 Ser350 in vivo, we raised a
polyclonal antibody against NDRG2 pSer350. The antibody
specifically recognized pSer350 NDRG2 but not the NDRG2
S350A mutant (Figure 3f and Supplementary Figure 3).
NDRG2 Ser350 phosphorylation was increased in a time-
dependent manner by DAPK1, but DAPK1 had no effect on
Ser350A mutant (Figure 3g).
Moreover, NDRG2, but not NDRG2 350A, was efficiently
phosphorylated byDAPK1 in vivo (Figure 3h). This recognition
was abolished by the dephosphorylation of NDRG2 with calf
intestinal phosphatase (CIP) (Figure 3i). We next evaluated
endogenous NDRG2 Ser350 phosphorylation levels in the
brains of WT and DAPK1 knockout (KO) mice. Ser350
phosphorylation of endogenous NDRG2 was detected in WT
brain lysates, but not in DAPK1 KO mice (Figure 3j). Finally,
phosphorylated NDRG2 Ser350 levels were significantly
increased in DAPK1ΔCaM-expressing cells compared with the
vector control- or DAPK1K42A-expressing cells (Figure 3k).
Taken together, these results show that DAPK1 phosphor-
ylates NDRG2 on only a Ser350 motif in vitro and in vivo.
DAPK1-induced NDRG2 phosphorylation promotes
neuronal cell death. Given the specific phosphorylation of
NDRG2 Ser350 by DAPK1, we next wanted to determine
whether this phosphorylation has any biological significance
or pathological consequence. Ceramide has important roles
in the regulation of neuronal cell differentiation, and it is
implicated in the pathological death of neurons that occurs in
AD.40,41 Moreover, ceramide is a potent DAPK1 activator and
induces DAPK1 kinase activity-mediated cell death in multi-
ple cell types including neuronal cells.12,14,42–44 Furthermore,
amyloid-β oligomer (Aβ) toxicity has a critical role in the
pathogenesis and progression of neuronal apoptosis and
memory loss in AD.45–47 However, the molecular mechan-
isms by which DAPK1 regulates neuronal cell death by
ceramide or Aβ have not been elucidated. When WT or
DAPK1 KO mouse primary cortical neurons were treated with
ceramide or Aβ, a live/dead cell assay revealed that
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ceramide- or Aβ-treated WT primary cortical neurons showed
highly increased cell death (Figure 4a and Supplementary
Figure 4a) and that DAPK1 ablation markedly attenuated
ceramide- or Aβ-induced neuron death (Figures 4a, b,
Supplementary Figures 4a and b). Moreover, when WT
mouse primary cortical neurons were pretreated with the
DAPK1 inhibitor before co-treatment with ceramide or Aβ, the
DAPK1 inhibitor significantly attenuated ceramide- or
Aβ-induced neuron death (Figures 4c, d, Supplementary
Figures 4c and d). Given that DAPK1 phosphorylates NDRG2
Ser350, we examined whether NDRG2 Ser350
phosphorylation affects ceramide-induced neuronal cell
death. Although phosphorylation-deficient form, NDRG2S350A
had no effect, its phosphorylation mimic forms, NDRG2S350D
and NDRG2S350E significantly increased cell death compared
with NDRG2 when WTor DAPK1 KO primary cortical neurons
were transfected with NDRG2, NDRG2S350A, NDRG2S350D or
NDRG2S350E (Figures 4e, f, Supplementary Figures 4e and f).
Moreover, WT NDRG2 increased cell death compared with
NDRG2S350A in WT primary cortical neurons, but not DAPK1
KO neurons (Figures 4e, f, Supplementary Figures 4e and f).
Taken together, these results show that NDRG2 Ser350
Figure 1 DAPK1 interacts with NDRG2 in vitro and in vivo. (a and b) Co-immunoprecipitation of DAPK1 and NDRG2 in vivo. 293T cells expressing FLAG-vector or
FLAG-DAPK1, and Myc-NDRG2 were subjected to immunoprecipitation with anti-Myc or FLAG antibody, followed by immunoblotting analysis with anti-FLAG or Myc antibody.
(c) Endogenous binding of DAPK1 and NDRG2. Mouse whole-brain lysates were subjected to immunoprecipitation with an anti-DAPK1 antibody, followed by immunoblotting
analysis with an anti-NDRG2 antibody. (d) DAPK1 and NDRG2 interaction in vitro. Glutathione-agarose beads containing GSTor GST-NDRG2 were incubated with extracts of
293T cells expressing FLAG-vector control or FLAG-DAPK1. After washing, proteins pulled down by GST beads were subjected to immunoblotting analysis with an anti-FLAG
antibody. (e) NDRG2 binding is not required the kinase activity of DAPK1. 293T cells expressing FLAG-DAPK1 or its mutants, DAPK1K42A or DAPK1ΔCaM were incubated with
glutathione-agarose beads containing GST-NDRG2. After washing, binding proteins were subjected to immunoblotting analysis with an anti-FLAG antibody. (f) Colocalization of
NDRG2 and DAPK1. HeLa cells were co-transfected with GFP-NDRG2 and either Myc-vector, Myc-DAPK1, Myc-DAPK1K42A or Myc-DAPK1ΔCaM, for 36 h followed by
immunofluorescent staining. All experiments are representative of three independent experiments
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phosphorylation increases its ability to induce neuronal cell
death and may be dependent on DAPK1 kinase activity.
Next, the effects of DAPK1 on the ability of NDRG2 to induce
cell death were further examined using cell culture systems.
Treatment with 20 μM of ceramide for 10 h or Aβ for 24 h in
DAPK1-overexpressing cells resulted in a twofold increase in
cell death compared with the vector control (Supplementary
Figures 5a and 6a). However, no difference could be detected
between the vector and DAPK1-expressing cells at440 μMof
ceramide or 30 μM of Aβ (Supplementary Figures 5a and 6a).
We therefore examined NDRG2-mediated cell death by
DAPK1 using 20 μM of ceramide or Aβ. When SH-SY5Y cells
were transfected with both DAPK1 and NDRG2, neuronal cell
death was increased compared with cells expressing DAPK1
or NDRG2 alone (Figure 5a and Supplementary Figure 5b).
NDRG2 was also capable of promoting DAPK1-mediated cell
death in DAPK1 KO mouse embryonic fibroblasts (MEFs)
(Supplementary Figure 5c). Next, we efficiently knocked down
endogenous DAPK1 expression using lentiviral-mediated
small hairpin RNA (shRNA) (Figure 5b). In contrast to the
control cells, when DAPK1 expression was suppressed, the
cell death was significantly decreased in NDRG2-
overexpressing cells (Figure 5b). Moreover, the inhibition of
DAPK1 using a DAPK1 inhibitor reduced ceramide-induced
cell death when NDRG2 was overexpressed (Figure 5c).
Furthermore, DAPK1K42A decreased, whereas DAPK1ΔCaM
increased NDRG2-mediated cell death compared with the
vector control (Figure 5d), suggesting that NDRG2-mediated
cell death is due to DAPK1 activity. In addition, DAPK1-
mediated neuronal cell death was reduced when the
endogenous NDRG2 expression was inhibited (Figure 5e).
Finally, NDRG2S350D and NDRG2S350E significantly increased
cell death, although NDRG2S350A transfection had no effect
compared with vector control, (Figure 5f). DAPK1 or NDRG2
overexpression/suppression had a similar effect on neuron
cell death with Aβ treatment (Supplementary Figures 6b-f). As
NDRG2S350A mutant did not increase DAPK1-mediated
neuronal cell death (Figures 6b and d), these data indicate
that DAPK1-dependent neuronal cell death may be mediated
by NDRG2 phosphorylation at Ser350.
DAPK1 regulates NDRG2-derived cell death through a
caspase-dependent pathway. Given that DAPK1 phosphor-
ylates NDRG2 and increases NDRG2-derived cell death, we
Figure 2 The identification of the domain in DAPK1 and NDRG2 required for their interaction. (a) Schematic representation of full-length DAPK1 and its truncated mutants.
*: A lysine was replaced by an alanine (K42→ A). (b) NDRG2 binding to the cytoskeleton-binding domain of DAPK1. Glutathione-agarose beads containing GSTor GST-NDRG2
were incubated with extracts of 293T cells expressing FLAG-DAPK1 or its truncated mutants. After washing, proteins pulled down by GST beads were subjected to
immunoblotting analysis with an anti-FLAG antibody. (c) The cytoskeleton-binding domain of DAPK1 directly interacts with NDRG2. Purified histidine-tag cytoskeleton-binding
domain of DAPK1 was incubated with glutathione-agarose beads containing GST or GST-NDRG2. After washing, proteins pulled down by GST beads were subjected to
immunoblotting analysis with an anti-His antibody. (d) The cytoskeleton-binding domain of DAPK1 is sufficient to interact with NDRG2. 293T cells expressing vector or the
cytoskeleton-binding domain of DAPK1 were incubated with glutathione-agarose beads containing GSTor GST-NDRG2. After washing, proteins pulled down by GST beads were
subjected to immunoblotting analysis with an anti-FLAG antibody. (e) A deletion of the cytoskeleton-binding domain of DAPK1 fails to bind to NDRG2. 293T cells expressing
FLAG-DAPK1 or its cytoskeleton-binding domain deletional mutants DAPK1ΔCyto, DAPK1K42AΔCyto or DAPK1ΔCaMΔCyto were incubated with glutathione-agarose beads
containing GST or GST-NDRG2. After washing, binding proteins were subjected to immunoblotting analysis with an anti-FLAG antibody. (f) DAPK1 interacts with NDRG2 on
C-terminus domain but not N-terminus domain. 293T cells expressing FLAG-DAPK1 were incubated with glutathione-agarose beads containing GST, GST-NDRG2, GST-NDRG2
(1–200) or GST-NDRG2 (201-371). After washing, binding proteins were subjected to immunoblotting analysis with an anti-FLAG antibody. All experiments are representative of
three independent experiments
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next wanted to determine the molecular mechanisms by
which DAPK1-mediated NDRG2 phosphorylation regulates
neuronal cell death. DAPK1-induced cell death has been
characterized as both a caspase-dependent and autophagic
cell death pathway depending on the stimuli or experimental
condition.1 To examine how DAPK1-mediated NDRG2 func-
tion may induce cell death, DAPK1 KO MEFs were co-
transfected with NDRG2 or NDRG2S350A, and DAPK1, and
caspase activity was evaluated by monitoring the cleavage of
poly-ADP-ribose polymerase (PARP) or caspase-3 after
ceramide treatment. The levels of cleaved PARP or caspase-
3 were markedly increased in both DAPK1- and NDRG2-
overexpressing cells (Figures 6a, b and Supplementary
Figure 7a). However, cleaved PARP or caspase-3 levels were
not increased when both DAPK1 and NDRG2S350A were
expressed (Figures 6a, b and Supplementary Figure 7a).
Moreover, autophagy cell death markers, P62 and LC3 A/B
were not increased or decreased in DAPK1 and NDRG2-
overexpressing cells (Figure 6a), indicating that DAPK1-
mediated NDRG2 function is required for the induction of a
caspase-dependent pathway. Furthermore, knockdown of
NDRG2 did not increase the levels of cleaved PARP or
caspase-3 even DAPK1 was overexpressed (Figures 6c, d and
Supplementary Figure 7b) and NDRG2S350D and
NDRG2S350E, but not NDRG2S350A significantly upregulated
cleaved PARP or caspase-3 levels (Figures 6e, f and
Supplementary Figure 7c). In addition, caspase inhibition by
Z-VAD-fmk, a pan-caspase inhibitor, abolished ceramide-
induced PARP cleavage or caspase-3 activity when both
DAPK1 and NDRG2 were co-expressed (Supplementary
Figures 7d-f). Overall, these results suggest that NDRG2 is
required for ceramide-induced programmed cell death, and
that DAPK1 may regulate NDRG2-derived cell death through
its phosphorylation and a caspase-dependent pathway.
DAPK1 regulates NDRG2 phosphorylation and neuronal
cell death in AD. Given that DAPK1 activates NDRG2
function through Ser350 phosphorylation and that NDRG2
overexpression induces neuronal cell death, we investigated
mouse hippocampal neuronal cell death in the WT and
DAPK1 KO under ceramide treatment. We first confirmed that
NDRG2 colocalized with NeuN, a neuron marker in the
hippocampus regions of mouse or human brains
(Supplementary Figure 8), as reported previously.37 Next,
the levels of DAPK1 and NDRG2 pSer350 were increased in
the hippocampal brain slices after ceramide or Aβ treatment
(Supplementary Figures 9a and b). When WT or DAPK1 KO
mouse brain slices were treated with 40 μM of ceramide, a
TUNEL assay revealed that ceramide-treated WT brain slices
showed highly increased cell death (Supplementary
Figure 9c) and that DAPK1 ablation markedly attenuated
ceramide-induced hippocampal neuron death
(Supplementary Figures 9c and d). To examine the possible
role of DAPK1 and NDRG2 on AD neuronal cell death in vivo,
we crossed DAPK1 KO mice with Tg2576 mice overexpres-
sing APP Swedish mutation.28 In the Tg2576/WT mice, the
levels of NDRG2 phosphorylation on Ser350 were signifi-
cantly higher than those of Tg2576/DAPK1 KO mice brain
(Figure 7a and Supplementary Figure 10). Moreover, DAPK1
expression was increased in the Tg2576/WT mice as
compared with non-transgenic (non-Tg) controls (Figure 7a
and Supplementary Figure 10). Furthermore, the number of
TUNEL-positive cells was significantly increased in the
hippocampi of Tg2576/WT mice compared with non-Tg
controls (Figures 7b and c). By contrast, in the Tg2576/
DAPK1 KO mice, neuronal cell death was attenuated to those
of the Tg2576/WT mice (Figures 7b and c). Taken together,
these results show that DAPK1 ablation reduces NDRG2
phosphorylation levels and neuronal cell death in AD animal
models.
Next, we investigated the potential association between
late-onset AD and phosphorylated NDRG2 Ser350 expres-
sion in normal and human AD brains. The expression of
NDRG2 pSer350 was increased more than threefold in the
AD patients compared with the normal subjects (Figures 7d
and e). Moreover, DAPK1 and phosphorylated tau Ser396
were highly overexpressed in the hippocampi of AD patients,
as described previously (Figure 7d).25 Furthermore, neurons
in normal hippocampus samples that contained low levels of
DAPK1 also had low levels of NDRG2Ser350 phosphorylation
in immunohistochemistry assay (Figure 7f). In contrast,
neurons from AD tissues that contained high levels of DAPK1
Figure 3 DAPK1 phosphorylates NDRG2 on Ser350 in vitro and in vivo. (a) DAPK1 phosphorylates NDRG2 in vitro. Purified recombinant DAPK1 was incubated with GST-
NDRG2 or GST-MLC and 32P-ATP, detected by autoradiography. *: 32P-auto-phosphorylated recombinant truncated DAPK1. (b) Time-dependent phosphorylation of NDRG2 by
DAPK1. Purified recombinant DAPK1 was incubated with GST-NDRG2 and 32P-ATP, detected by autoradiography. (c) Double reciprocal (Lineweaver–Burk) plots for analyzing the
kinetic parameters of NDRG2 or phosphorylation catalyzed by DAPK1. The initial velocities (V0) were measured using purified recombinant DAPK1 at increasing substrate
concentrations. (d) DAPK1 phosphorylates NDRG2 on C-terminus domain but not N-terminus domain. Purified recombinant DAPK1 was incubated with GST-NDRG2, GST-
NDRG2 (1–200) or GST-NDRG2 (201–371), and 32P-ATP, detected by autoradiography. *: 32P-auto-phosphorylated recombinant truncated DAPK1. (e) DAPK1 phosphorylates
NDRG2 on Ser350 in vitro. Purified recombinant DAPK1 was incubated with GST-NDRG2, GST-NDRG2-Ser326A, GST-NDRG2-Thr330A, GST-NDRG2-Ser332A, GST- NDRG2-
Ser346A, GST-NDRG2-Thr348A, or GST-NDRG2-Ser350A, and 32P-ATP, detected by autoradiography. *: 32P-auto-phosphorylated recombinant truncated DAPK1. (f) DAPK1
phosphorylates NDRG2 but not NDRG2-Ser350A. Purified recombinant DAPK1 was incubated with GST, GST-NDRG2 or GST-NDRG2 S350A, and ATP, followed by
immunoblotting analysis with an anti-pSer350 NDRG2 antibody. (g) Time-dependent phosphorylation of NDRG2 Ser350 by DAPK1. Purified recombinant DAPK1 was incubated
with GST-NDRG2 or NDRG2 S350A, and ATP, followed by immunoblotting analysis with an anti-pSer350 NDRG2 antibody. (h) DAPK1 phosphorylates NDRG2 in vivo. 293T cells
expressing Myc-vector, Myc-NDRG2 or Myc-NDRG2-Ser350A mutant, and FLAG-DAPK1 were subjected to immunoprecipitation with Myc antibody, followed by immunoblotting
analysis with anti-pSer350 NDRG2 or anti-FLAG antibodies. (i) CIP treatment abolishes NDRG2 phosphorylation. 293T cells expressing Myc-vector, Myc-NDRG2 or Myc-
NDRG2-Ser350A with FLAG-DAPK1 were subjected to immunoblotting analysis with an anti-pSer350 NDRG2 antibody in the presence or absence of CIP. *: Nonspecific band. (j)
Endogenous phosphorylation of NDRG2 by DAPK1. Total brain lysates from WTor DAPK1 KO mice were subjected to immunoblotting analysis with anti-pSer350-NDRG2, anti-
NDRG2, anti-DAPK1, or anti-actin antibodies. (k) DAPK1 kinase activity-dependent phosphorylation of NDRG2. 293T cells expressing FLAG-vector or FLAG-DAPK1K42A or
FLAG-DAPK1ΔCaM with Myc-NDRG2 were subjected to immunoblotting analysis with an anti-pSer350 NDRG2 antibody. All experiments are representative of three independent
experiments
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also had high levels of NDRG2 Ser350 phosphorylation
(Figure 7f). In addition, in human AD brain, phosphorylated
NDRG2 Ser350 and DAPK1 were colocalized in the cyto-
plasm of neuron (Figure 7g). These results indicate that
NDRG2 Ser350 phosphorylation is upregulated in the
hippocampi of AD patients, which further supports the idea
that DAPK1 is a NDRG2 Ser350 kinase.
Discussion
Although the cumulative evidence indicates that DAPK1 may
have a critical role in neuronal cell death and AD, the
underlying mechanisms and overall impact on AD are still
unknown. A key step toward understanding how DAPK1
regulates neuronal cell death and AD will be to develop
systematic approaches for identifying the major DAPK1
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substrates in AD and for determining their function and
regulation by DAPK1. To address these questions, we used
positional scanning peptide libraries to identify the optimal
substrate phosphorylation motif for DAPK1. Based on these
findings, we further identified numerous putative DAPK1
substrates using a proteome-wide search for sites that
correspond to the DAPK1 phosphorylation motif. However,
confirmation that DAPK1 substrates are, indeed, important in
neuronal cell death and AD may require a substantial number
of both in vitro and in vivo experiments. The rationale for
selecting which targets to study first was based on several
criteria, including whether they had been previously identified
as well as whether they have known roles in the cell death and
neuronal function involved in AD. As a result of these
processes, we decided to first focus on NDRG2, as a novel
DAPK1 substrate potentially involved in neuronal cell death
and AD.
In this study, DAPK1 was shown to be a critical regulator of
NDRG2 function and neuronal cell death in vitro and in vivo.
First, DAPK1was found to associate with NDRG2, and the two
proteins colocalized in the cytoplasm of cells. Second, DAPK1
was found to phosphorylate only NDRG2 Ser350 in vitro and
in vivo. Third, this phosphorylation increased NDRG2-
mediated neuronal cell death. Fourth, Ser350 phospho-
mimicking mutations fully activated NDRG2-mediated
neuronal cell death, whereas Ser350 non-phosphorylation
mutation completely inactivated its apoptotic function. Fifth,
DAPK1 and NDRG2 promoted neuronal cell death through
a caspase-dependent pathway. Sixth, DAPK1 ablation
decreased NDRG2 Ser350 phosphorylation and neuronal cell
death in the APP-overexpressing mouse brains. Finally,
phosphorylated NDRG2 Ser350 and DAPK1 levels were
highly upregulated in the brain tissues of AD patients. Thus,
NDRG2 cellular function is fully activated by DAPK1-mediated
Ser350 phosphorylation.
We found that the co-expression of DAPK1 and NDRG2
significantly increased neuronal cell death and that
DAPK1K42A and NDRG2S350A failed to enhance cell death
Figure 4 DAPK1 inhibition or NDRG2 dephosphorylation attenuates ceramide-induced primary neuronal cell death. (a) DAPK1 ablation attenuated ceramide-induced
primary neuronal cell death. Primary cortical cultures derived from the cerebral cortex of day 15 (E15) WTor DAPK1 KOmice in DIV7 were treated ceramide (20 μM) for the 24 h,
followed by color live-dead cell assay. Scale bar= 50 μm. (b) Cells expressing red or green color were scored in 200 cells. Results shown are mean± error bar (**Po0.01). (c)
DAPK1 inhibition suppressed ceramide-induced primary neuronal cell death. Primary cortical cultures derived from the cerebral cortex of day 15 (E15) WT mice in DIV7 were
treated DAPK1 inhibitor (100 nM) for 12 h, and then treated ceramide (20 μM) for the 24 h, followed by color live-dead cell assay. Scale bar= 50 μm. (d) Cells expressing red or
green color were scored in 200 cells. Results shown are mean± error bar (**Po0.01). N.S, no significance. (e) NDRG2-Ser350D and NDRG2-Ser350E mutations increased
primary neuronal cell death. DAPK1 KOmice primary cortical neurons in DIV7 were transfected with GFPor GFP-NDRG2, its mutants S350A, S350D, or S350E for 48 h and then
treated ceramide (20 μM) for 10 h. Cell death was determined by TUNEL assay using the confocal microscope. Scale bar= 50 μm. (f) TUNEL-positive neurons were scored in
200 cells. Results shown are mean± error bar (**Po0.01). All experiments are representative of three independent experiments
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after ceramide treatment, suggesting that DAPK1 kinase
activity is critical for neuronal cell death. Moreover, NDRG2-
mediated cell death significantly decreasedwith knockdown of
DAPK1 expression or DAPK1 inhibitor treatment. Further-
more, DAPK1-mediated NDRG2 phosphorylation promoted
the cleavage of caspase-3 and PARP, suggesting that DAPK1
and NDRG2might act to induce cell death through a caspase-
dependent pathway. As DAPK1 is linked to both caspase-
dependent and caspase-independent cell death in response
to different stimuli1 and given that ceramide or Aβ increases
DAPK1 activity,14,43,44,48 our data suggest a model in which
DAPK1 stimulates caspase-dependent neuronal cell death
following ceramide or Aβ induction via NDRG2 phosphoryla-
tion at Ser350 (Supplementary Figure 11). It is known that
ceramide stimulates generation of reactive oxygen species
and promotes apoptosis by inhibition of the phosphoinositide
3-kinase (PI3K)/Akt pathway via PP2A, or activation of JNK or
p38 MAPK cascades.49 Recent studies have reported that
DAPK1 is involved in MAPKs signaling pathways under
oxidative stress3 and its activity is critical for ceramide-induced
apoptosis.12,14,43 In addition, PP2A-mediated dephosphoryla-
tion of DAPK1 can trigger UNC5H2-induced apoptosis.50
Moreover, NDRG2 activates JNK pathway and is a negative
regulator of PI3K/Akt pathway by promoting the active depho-
sphorylated form of PTEN through the recruitment of
PP2A.51,52 Taking these findings together, it could be specu-
lated that NDRG2 phosphorylation by DAPK1 is activated
under ceramide treatment, leading to the downregulation of
PI3K/Akt and/or activation of JNK pathways, thereby inducing
apoptosis by activating Bad, GSK-3β and caspase-3.
The most interesting aspect of this study was the
potential association between late-onset AD and phosphory-
lated NDRG2 Ser350 because DAPK1 is highly expressed in
AD brains. Phosphorylated NDRG2 Ser350 levels were
measured in the hippocampi of AD patients and normal
controls because, in AD, the hippocampus is damaged
early and severely compared with other parts of the cortex
and because DAPK1 expression is restricted to the
Figure 5 NDRG2-dependent neuronal cell death is mediated by DAPK1 kinase activity. (a) SH-SY5Y cells were co-transfected with Myc-vector or Myc-NDRG2 and FLAG-
DAPK1 and then treated ceramide (20 μM) for the 10 h, followed by Trypan blue staining. Results shown are mean± error bar, n= 3. (*Po0.05, **Po0.01). (b) DAPK1
knockdowned SH-SY5Y cells were transfected with Myc-vector, Myc-NDRG2 or Myc-NDRG2 S350A and then treated ceramide (20 μM) for the 10 h, followed by Trypan blue
staining. Results shown are mean± error bar, n= 3. (*Po0.05, **Po0.01). N.S, no significance. (c) WT MEFs were transfected with Myc-vector or Myc-NDRG2 and then
pretreated with 100 nM DAPK1 inhibitor for 12 h before the co-treatment with ceramide (20 μM) for 10 h, followed by Trypan blue staining. Results shown are mean± error bar,
n= 3. (*Po0.05, **Po0.01). (d) SH-SY5Y cells expressing Myc-NDRG2 or Myc-S350A, and FLAG-DAPK1, its mutants, DAPK1K42A or DAPK1ΔCaM were treated ceramide
(10 μM) for 10 h, followed by Trypan blue staining. Results shown are mean± error bar, n= 3 (**Po0.01). (e) NDRG2 knockdowned SH-SY5Y cells were transfected with FLAG-
vector or FLAG-DAPK1 and then treated ceramide (20 μM) for the 10 h, followed by Trypan blue staining. Results shown are mean± error bar, n= 3. (**Po0.01). (f) SH-SY5Y
cells were transfected with Myc or Myc-NDRG2, its mutants S350A, S350D, or S350E and then treated ceramide (20 μM) for the 10 h, followed by Trypan blue staining. Results
shown are mean± error bar, n= 3. (**Po0.01). All experiments are representative of three independent experiments
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hippocampus of the adult brain.53 We found that hippocampal
tissues from aged AD brains had increased levels of
phosphorylated NDRG2 Ser350 protein along with high levels
of DAPK1 relative to those from age-matched normal subjects.
As neuronal loss is an essential event in AD progression and
eventually leads to dementia, the critical role of DAPK1
and NDRG2 in neuronal cell death shown in this study
substantiates the need for further studies on both proteins in
neuronal cells. Future studies should include the development
of Tg mice with inducible and brain-restricted DAPK1
expression and DAPK1 KO/Tg mice crossed with NDRG2
mouse models.
Figure 6 DAPK1 and NDRG2 promote neuronal cell death through caspase-dependent pathway. (a) DAPK1 KO MEFs were co-transfected with Myc-vector, Myc-NDRG2 or
Myc-S350A and FLAG-DAPK1 and then treated ceramide (20 μM) for the 10 h, followed by immunoblotting analysis with anti-PARP, anti-caspase-3, anti-p62 or anti-LC3
antibodies. (b) Quantitation of cleaved PARP. Results shown are mean± error bar, n= 3. (**Po0.01). (c) NDRG2 knockdowned SH-SY5Y cells were transfected with FLAG-
vector or FLAG-DAPK1 and then treated ceramide (20 μM) for the 10 h, followed by immunoblotting analysis with anti-PARP and anti-caspase-3 antibodies. (d) Quantitation of
cleaved PARP. Results shown are mean± error bar, n= 3. (**Po0.01). (e) DAPK1 KO MEFs were transfected with Myc or Myc-NDRG2, its mutants S350A, S350D or S350E
and then treated ceramide (20 μM) for the 10 h, followed by immunoblotting analysis with anti-PARP and anti-caspase-3 antibodies. (f) Quantitation of cleaved PARP. Results
shown are mean± error bar, n= 3. (**Po0.01). All experiments are representative of three independent experiments
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Taken together, these findings suggest that DAPK1 speci-
fically phosphorylates NDRG2 Ser350 and this phosphoryla-
tion is an important caspase-dependent mechanism by which
NDRG2 mediates cell death in neuronal cells. Furthermore,
our results also show that phosphorylated NDRG2 Ser350
levels are increased in AD brains, and this may be a marker of
AD pathology. Overall, our data suggest a model in which
DAPK1 activates NDRG2 function via Ser350 phosphorylation
followed by neuronal cell death through the cleavage of
caspase-3 and PARP. Moreover, our studies suggest that
DAPK1 represents a potential novel therapeutic approach for
treating AD.
Materials and Methods
Materials. C6-ceramide, paraformaldehyde and dimethyl sulfoxide were purchased
from Sigma (St. Louis, MO, USA). DAPK1 inhibitor (4Z)-4-(3-pyridylmethylene)-2-
styryl-oxazol-5-one was obtained from Calbiochem (Billerica, MA, USA). Caspase-3
colorimetric assay kit was purchased from BioVision (Milpitas, CA, USA).
Preparation of Aβ solution. Synthetic Aβ25–35 peptides corresponding to
WT human Aβ was obtained from Genemed Synthesis, Inc. (San Antonio, TX,
USA). Aβ25–35 peptide stock solution was dissolved in 2 ml of Millipore (Billerica,
MA, USA) SuperQ water; solutions were fractionated into five equal parts and
lyophilized overnight. Each aliquot was dissolved in water (pH 7.4) to achieve the
needed concentration.
Cell culture. The human cervix carcinoma cell line HeLa; the human
neuroblastoma cell lines SH-SY5Y; the human embryonic kidney 293T were
obtained from the American Type Culture Collection (Manassas, VA, USA). MEFs
were obtained from the WT and DAPK1 KO embryos between embryonic day 12.5
and 14.5. HeLa, SH-SY5Y, 293T and MEF cells were cultured in Dulbecco’s
modified Eagle’s medium high-glucose supplemented with 10% fetal bovine serum,
100 U/ml penicillin and 100 μg/ml streptomycin (all from Life Technologies,
Waltham, MA, USA). The cultures were maintained at 37 °C under 5% CO2.
Plasmid transfection. The expression constructs for WTand various mutants
of DAPK1 with C-terminal FLAG tag were described.6 FLAG-DAPK1 deletion
mutants were generated by PCR. The cytoskeleton deletion DAPK1 variants
(DAPK1 ΔCyto: residues 648-841) were generated by PCR. Cells were transiently
Figure 7 NDRG2 Ser350 phosphorylation levels are significantly increased in the APP Tg mouse brain and human AD hippocampus. (a) Brain lysates from 8-month-old non-
Tg control, Tg2576/WT or Tg2576/DAPK1 KO mice were subjected to immunoblotting analysis with anti-pSer350-NDRG2, anti-NDRG2, anti-DAPK1, anti-APP or anti-actin
antibodies. (b) Apoptosis of paraffin-embedded brain sections from 8-month-old non-Tg control, Tg2576/WT or Tg2576/DAPK1 were examined by TUNEL assay. Scale
bar= 20 μm. (c) Summary of the percentage of TUNEL-positive cells from the hippocampus regions of non-Tg control, Tg2576/WTor Tg2576/DAPK1 mice. (d) Hippocampal
tissues of 10 AD patients and 8 age-matched controls were harvested. Proteins from normal and AD hippocampus were used for immunoblotting analysis with anti-pSer350-
NDRG2, anti-DAPK1, anti-pS396-Tau or anti-actin antibodies. (e) Anti-pSer350 intensities were quantified by computer densitometry (*Po0.05 versus normal control; ANOVA/
Dunnett’s test). (f) Immunohistochemistry of paraffin-embedded brain serial sections from normal and AD hippocampus, comparing the levels of DAPK1 and phosphorylated
NDRG2 on Ser350. x200 (insets); Scale bar= 100 μm. All experiments are representative of three independent experiments. (g) Immunofluorescence using a monoclonal
antibody specific for DAPK1 or a polyclonal antibody specific for phosphorylated NDRG2 Ser350 was conducted on hippocampus regions from human AD brain. Scale
bar= 50 μm. Representative images from five experiments are shown
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transfected with different plasmids using Lipofectamine 2000 (Life Technologies),
PolyJet (Sigmagen, Rockville, MD, USA) or DNA-IN Neuro (GlobalStem,
Gaithersburg, MD, USA) transfection reagents according to the manufacturer’s
instruction. For generating stable NDRG2 overexpression SH-SY5Y cells, a NDRG2
clone that is constructed within lentiviral pByBE.1. Blastidine vector was transfected
together with VSV-G- and gag-pol-expressing plasmids into 293FT cells. Sixty hours
after transfection, virus-containing supernatants were used to infect the SH-SY5Y
cells. A day after infection, the stable clones were selected using 1.5 μg/ml
blastidine. For generating stable DAPK1 or NDRG2 knockdown SH-SY5Y cells,
DAPK1 or NDRG2 shRNA clones, which are constructed within lentiviral pLKO.1-
Puro vector, were transfected together with VSV-G- and gag-pol-expressing
plasmids into 293FT cells. Sixty hours after transfection, virus-containing
supernatants were used to infect the SH-SY5Y cells. A day after infection, the
stable clones were selected using 1.5 μg/ml puromycin. The target sequences of
DAPK1-specific shRNA was 5′-CAAGAAACGTTAGCAAATG-3′ and the target
sequences of NDRG2-specific shRNA was 5′-CCGGCTGGAAGAGATG
TCCTAATATCTCGAGATATTAGGACATCTCTTCCAGTTTTTTG-3′.
Primary cortical neuronal cell cultures in mice. Primary cultures of
mouse embryonic cortical neurons were prepared as described previously.54,55
Briefly, dissociated embryonic neurons from embryonic day 15 (E15) WT or DAPK1
KO C57BL/6 pregnant mice were resuspended in neurobasal medium supple-
mented with 2% B27 supplement, 0.5 mM glutamine and 1% penicillin–streptomycin
(all from Life Technologies) and cultured at 37 °C under 5% CO2. After adaptation
for 24 h, the culture medium was replaced with a neurobasal-A medium containing
2% B27 supplement, 0.5 mM glutamine and 1% penicillin–streptomycin. Primary
cortical neuronal cells were used for ceramide or Aβ oligomer-induced neuronal cell
death at day in vitro (DIV) 7.
Organotypic brain-slice cultures. Organotypic mouse brain-slice cultures
were performed as described previously.25 Briefly, brains from 6-month-old WT and
DAPK1 KO mice were removed and cut into coronal slices of 260-μm thicknesses
with vibratome (Leica, Buffalo Grove, IL, USA). Slices containing the hippocampus
were used for neuronal cell death using TUNEL assay. The slices were cultured
onto organotypic Millicell cell culture inserts (Millipore) in six-well culture plates with
culture medium.
Immunohistochemistry and immunostaining analyses. Immersion-
fixed tissue (hippocampus) sections were embedded in paraffin. Coronal tissue
sections were deparaffinized with xylene, rehydrated with descending grade of
ethanol and incubated with 3% H2O2/PBS to quench the endogenous peroxidase
activity. After antigen retrieval, sections were incubated in PBS blocking buffer with
5% horse serum, 5% bovine serum albumin and 0.1% v/v Tween 20. Primary
antibodies were added in blocking buffer and incubated with sections overnight at
4 °C. For immunohistochemical analysis, secondary antibody was biotinylated goat-
anti-rabbit or -mouse IgG. Sections were processed with ABC reagents by using a
Vector ABC kit (Vector Laboratories, Burlingame, CA, USA). After washing, the
horseradish peroxidase (HRP) reaction was detected with diaminobenzidine and
H2O2. For immunofluorescent analysis, slides were incubated with Alexa488-labeled
anti-mouse IgG and Alexa546-labeled anti-Rabbit IgG (Invitrogen, Carlsbad, CA,
USA) diluted 1:200 for 2 h at room temperature. After washing with PBS, the nuclei
were stained with DAPI for 10 min at room temperature.
Immunoblot analysis. After harvesting, the cells were lysed in ice-cold
lysis buffer (50 mM Tris-HCl (pH 7.4), 50 mM NaCl, 1 mM EGTA, 1% Triton X-100,
1 mM DTT) supplemented with protease inhibitor cocktail and phosphatase inhibitor
cocktail. Mouse and human brain extracts were prepared by homogenizing tissue in
ice-cold lysis buffer (10 mM Tris-HCl (pH 7.4), 0.8 M NaCl, 1 mM EGTA, 10%
sucrose, 1 mM DTT) supplemented with protease inhibitor cocktail and
phosphatase inhibitor cocktail. The soluble protein concentration was determined
by Bradford assay (Bio-Rad, Hercules, CA, USA). Protein samples (5–10 μg) were
separated by SDS-PAGE using a 26-well electrophoresis system (Bio-Rad) and
transferred to polyvinylidene fluoride membranes (PerkinElmer, Waltham, MA,
USA). The membranes were then probed with various antibodies, followed by HRP-
conjugated secondary antibodies. Antibody-bound proteins were detected using the
Western Lightning Plus-ECL (PerkinElmer) or ECL Prime (GE Healthcare Life
Sciences, Marlborough, MA, USA) chemiluminescence system. The following
antibodies were used to probe different proteins: His, NDRG2 (Santa Cruz, Dallas,
TX, USA); FLAG, DAPK1 (Sigma); β-actin, Myc, GFP, cleaved PARP, cleaved
caspase-3, p62, LC3 A/B (Cell Signaling Technology, Danvers, MA, USA); PHF-13
(p-Ser396-Tau) (Anaspec, Fremont, CA, USA).
Phosphorylated Ser350-specific NDRG2 antibodies. Phosphory-
lated Ser350-specific NDRG2 antibodies were raised by immunizing rabbits with
a KLH-coupled pSer350-containing NDRG2 peptide CSRSTLSQSSE (Neobio Lab,
Woburn, MA, USA) and were affinity purified, as described.29
GST pull-down, in vitro kinase, and immunoprecipitation. GST
pull-down, in vitro kinase and immunoprecipitation analyses were performed as
described previously.29 Briefly, relevant proteins were expressed in 293T or Hela
cells by transient transfection, followed by lysis or dilution in a buffer containing
50 mM Tris-HCl (pH 7.4), 50 mM NaCl, 1 mM EGTA, 1% Triton X-100, and 1 mM
DTT supplemented with protease inhibitor cocktail and phosphatase inhibitor
cocktail. The cellular supernatants were incubated with 1 μM GST or GST fusion
proteins or specific antibodies for 1 h at 4 °C and 15 μl of glutathione-agarose
beads or protein A agarose were then added, followed by further incubation for 2 h
at 4 °C. The precipitated proteins were washed 4–6 times in the same buffer and
subjected to immunoblotting analysis. For in vitro kinase assays, purified
recombinant DAPK1 was incubated with GST-NDRG2 or MLC in the kinase
reaction buffer at 25 °C for up to 30 min, detected by autoradiography. For
measuring steady-state kinetic parameters, 1 μg of DAPK1 was used to catalyze
increasing amounts of MLC or NDRG2 (0.7–8.4 μM) in 25 μl of kinase reaction
mixture. In immunoprecipitation, relevant proteins were incubated with Myc or FLAG
M2 bead or nonspecific IgG or monoclonal mouse anti-DAPK1 at 4 °C for 3 h,
followed by the addition of 15 μl of Protein G-Sepharose (Sigma) for 2 h at 4 °C,
followed by immunoblotting analysis.
Cell viability assays. Cell viability was assessed with a live/dead Viability Kit
(Abcam, Cambridge, MA, USA) or Trypan blue staining according to the
manufacturer’s instruction. Briefly, primary neuron at DIV 9 diluted with equal
volumes of cell suspension and 2X live/dead dye solution, incubation for 10 min at
room temperature in the dark. Cell viability was analyzed using fluorescent
microscopy. For the Trypan blue staining, cell collections were diluted in Trypan blue
dye (Sigma) by preparing a 1:1 dilution of the cell suspension using a 0.4% Trypan
blue solution for 5 min. Cell viability was analyzed using hemocytometer.
TUNEL assay. TUNEL assay was carried out using in situ cell death detection
kit, TMR red (Roche Group, Indianapolis, IN, USA) according to the manufacturer
protocols. Briefly, primary neurons or brain slices treated with ceramide were
incubated with TUNEL reagent (labeled with TMR red) at 37 °C for 1 h. TUNEL-
positive cell density was calculated as number of apoptotic cells per square
millimeter of section.
Caspase-3 activity assay. Caspase-3 activity assay was carried out using
Caspase-3 colorimetric assay kit (BioVision) according to the manufacturer
protocols. Briefly, cells treated with ceramide were incubated with reaction buffer
and DEVD-pNA substrate at 37 °C for 1 h. Caspase-3 activity was measured at
405 nm in a microtiter plate reader.
Brain samples. Whole-brain tissues from WTand DAPK1 KO mice at 6 months
of age and from non-Tg, Tg2576/WT and Tg2576/ DAPK1 KO mice at 8 months of
age were harvested. WT, DAPK1 KO or Tg2576 mice were previously
described.7,25,28,56 WT or DAPK1 KO mice were maintained in pure C57BL/6
background. Tg2576 or Tg2576/DAPK1 KO mice were maintained in C57BL/6 × SJL
hybrid background. Tg2576 mice in C57BL/6 × SJL F1 hybrid background
were initially crossed with DAPK1 KO in C57BL/6 background to obtain
Tg2576:DAPK1+/− and control non-Tg:DAPK1+/− . The mice analyzed for the
study were derived from the cross of Tg2576:DAPK1+/− and non-Tg:DAPK1+/−
in order to maintain the hemizygosity of Tg2576. After extraction, whole brains were
snap frozen in liquid nitrogen-cold isopentane and stored at − 80 °C until use. Total
brain lysates were obtained from these mouse brain tissues. Brain hippocampus
tissues of human Alzheimer’s patients and controls were obtained from the
Neuropathology Core of the Massachusetts Alzheimer’s Disease Research Center
(Boston, MA, USA) and the Harvard Brain Tissue Resource Center (Boston, MA,
USA). Research was conducted in compliance with the policies and principles
contained in the Federal Policy for the Protection of Human subjects. In most cases,
brain hippocampus tissues obtained within 30 h post mortem were used; 10 from
DAPK1 regulates neuronal cell death through NDRG2
M-H You et al
248
Cell Death and Differentiation
individuals with a clinical diagnosis of probable AD and 8 from individual without any
neurological disorder (Supplementary Table 2).
Statistical analysis. The data are presented as means± S.E. of the three
independent experiments. Statistical significances were calculated by one-way
analysis of variance (ANOVA) followed by Dunnett’s multiple comparison post-hoc
test. GraphPad Prism version 4.0 (La Jolla, CA, USA) was used for statistical
analyses.
Study approval. All animal generation, husbandry and experimental proce-
dures were approved by the Beth Israel Deaconess Medical Center’s Institutional
Animal Care and Use Committee, and conform to the NIH guidelines of the care and
use of laboratory animals. All studies on human samples were approved by the
Institutional Review Boards at the Beth Israel Deaconess Medical Center.
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